1. Home
  2. EVO vs KW Comparison

EVO vs KW Comparison

Compare EVO & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • KW
  • Stock Information
  • Founded
  • EVO 1993
  • KW 1977
  • Country
  • EVO Germany
  • KW United States
  • Employees
  • EVO N/A
  • KW N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • KW Real Estate
  • Sector
  • EVO Health Care
  • KW Finance
  • Exchange
  • EVO Nasdaq
  • KW Nasdaq
  • Market Cap
  • EVO 1.6B
  • KW 1.4B
  • IPO Year
  • EVO 2021
  • KW 1992
  • Fundamental
  • Price
  • EVO $3.60
  • KW $6.79
  • Analyst Decision
  • EVO Buy
  • KW Hold
  • Analyst Count
  • EVO 2
  • KW 1
  • Target Price
  • EVO $5.90
  • KW $13.00
  • AVG Volume (30 Days)
  • EVO 101.3K
  • KW 918.3K
  • Earning Date
  • EVO 04-17-2025
  • KW 05-07-2025
  • Dividend Yield
  • EVO N/A
  • KW 7.07%
  • EPS Growth
  • EVO N/A
  • KW N/A
  • EPS
  • EVO N/A
  • KW N/A
  • Revenue
  • EVO $825,103,013.00
  • KW $511,600,000.00
  • Revenue This Year
  • EVO $3.70
  • KW $30.34
  • Revenue Next Year
  • EVO $10.32
  • KW $4.80
  • P/E Ratio
  • EVO N/A
  • KW N/A
  • Revenue Growth
  • EVO 1.99
  • KW N/A
  • 52 Week Low
  • EVO $2.84
  • KW $6.34
  • 52 Week High
  • EVO $7.77
  • KW $11.88
  • Technical
  • Relative Strength Index (RSI)
  • EVO 56.15
  • KW 31.54
  • Support Level
  • EVO $3.27
  • KW $6.60
  • Resistance Level
  • EVO $3.40
  • KW $6.95
  • Average True Range (ATR)
  • EVO 0.14
  • KW 0.44
  • MACD
  • EVO 0.07
  • KW -0.08
  • Stochastic Oscillator
  • EVO 84.44
  • KW 18.75

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

Share on Social Networks: